Company Search:
Advanced Search
Sponsored Links
EirGenix Inc Company Snapshot
EirGenix Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares EirGenix Inc with three other pharmaceutical manufacturers in Asia: Cellumed Co Ltd of South Korea (2016 sales of 9.81 billion Korean Won [US$9.22 million] ), Mycenax Biotech Incorporated (200.61 million Taiwanese Dollars [US$6.87 million] of which 100% was Biological Medicine), and Tego Science Inc which is based in South Korea (8.34 billion Korean Won [US$7.83 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
EirGenix Inc
  Stock Performance Chart for EirGenix Inc
  Stock Data: Recent Stock Performance:
  Current Price (3/16/2018): 27.50
(Figures in Taiwanese Dollars)
1 Week -3.8%   13 Weeks 9.1%  
4 Weeks 2.2%   52 Weeks -31.4%  
EirGenix Inc Key Data:
  Ticker: 6589 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 253,107,000
(Year Ending Jan 2017).
Employees: 145
  Currency: Taiwanese Dollars Market Cap: 2,842,004,591
  Fiscal Yr Ends: December Shares Outstanding: 103,345,622
  Share Type: GU Closely Held Shares: N/A
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.